← Open Payments lookup

ELIZABETH VALLEJO: Open Payments

NPI 1679896856 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$706 in 35 payments from 14 companies in 2025. Trend: 2023 $719 · 2024 $427 · 2025 $706

Food & beverage: $706
CompanyPaymentsAmount
Gilead Sciences, Inc.6$144
RECORDATI_RARE_DISEASES_INC.1$97
Boehringer Ingelheim Pharmaceuticals, Inc.5$94
ABBVIE INC.4$85
Novo Nordisk Inc5$77
Dexcom, Inc.2$39
AstraZeneca Pharmaceuticals LP2$32
Phathom Pharmaceuticals, Inc.4$29
Alnylam Pharmaceuticals Inc.1$21
Otsuka America Pharmaceutical, Inc.1$18

Products named: Epclusa, PANHEMATIN, JARDIANCE, VRAYLAR, Dexcom G6 Transmitter, FARXIGA, QULIPTA, Ozempic.

Industry payments across TX — which companies pay providers there.